ACTELION PHARMACEUTICALS US, INC.
ACTELION PHARMACEUTICALS US, INC. has won 285 federal awards worth $9.4M in total across 2 agencies, with a median award of $18K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| OPSUMIT 10MG-QTY 3 @ $12,853.56 MAY ORDER HOME CONFINEMENT 90 DAYS' SU | Department Of Justice | $39K | 2026-06-03 |
| FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) SEPTEMBER | Department Of Justice | $62K | 2026-04-23 |
| FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) AUGUST | Department Of Justice | $62K | 2026-04-23 |
| FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) JULY | Department Of Justice | $62K | 2026-04-23 |
| FY26-PHARMACY APRIL | Department Of Justice | $62K | 2026-04-23 |
Questions
How many federal contracts has ACTELION PHARMACEUTICALS US, INC. won?
285 awards on record, worth $9.4M in total across 2 agencies. The median award is $18K.
Which agencies buy from ACTELION PHARMACEUTICALS US, INC.?
Mostly Department Of Veterans Affairs, Department Of Justice.
Is ACTELION PHARMACEUTICALS US, INC. a competitor worth watching?
That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.
Agencies they win from
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
$49 per report. No subscription, no account needed to see pricing.